BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hoffmann P, Jung V, Behnisch R, Gauss A. Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis. World J Gastroenterol 2020; 26(46): 7367-7381 [PMID: 33362390 DOI: 10.3748/wjg.v26.i46.7367]
URL: https://www.wjgnet.com/1007-9327/full/v26/i46/7367.htm
Number Citing Articles
1
Ludovico Abenavoli, Lidia Giubilei, Anna Caterina Procopio, Rocco Spagnuolo, Francesco Luzza, Luigi Boccuto, Emidio Scarpellini. Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex InterplayNutrients 2022; 14(24): 5323 doi: 10.3390/nu14245323
2
Alireza Beheshti Maal, Mohammad Amin Shahrbaf, Bahareh Sadri, Nikoo Hossein-Khannazer, Mohammad Ali Mansournia, Massoud Vosough. Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million PatientsJournal of Crohn's and Colitis 2024; 18(3): 360 doi: 10.1093/ecco-jcc/jjad157
3
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic AgentsJournal of Crohn's and Colitis 2022; 16(5): 852 doi: 10.1093/ecco-jcc/jjab212
4
Athri Kodali, Chiugo Okoye, Dhadon Klein, Iman Mohamoud, Olawale O Olanisa, Panah Parab, Priti Chaudhary, Sonia Mukhtar, Ali Moradi, Pousette Hamid. Crohn’s Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic ReviewCureus 2023;  doi: 10.7759/cureus.42995
5
Qijin Hong, Jun Shen, Qi Feng, Qing Zheng, Yuqi Qiao. Prevalence and predictors of non-alcoholic liver disease on MRI among patients with Crohn's diseaseBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02238-5
6
Ludovico Abenavoli, Rocco Spagnuolo, Giuseppe Guido Maria Scarlata, Emidio Scarpellini, Luigi Boccuto, Francesco Luzza. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional StudyMedicina 2023; 59(11): 1935 doi: 10.3390/medicina59111935
7
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disordersWorld Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
8
Mohammad Zamani, Shaghayegh Alizadeh‐Tabari, Siddharth Singh, Rohit Loomba. Meta‐analysis: prevalence of, and risk factors for, non‐alcoholic fatty liver disease in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2022; 55(8): 894 doi: 10.1111/apt.16879
9
Samuel J. Martínez-Domínguez, Sandra García-Mateo, Carla J. Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau, Carolina Mendi, Pedro M. Baptista, María Hernández Ainsa, María Teresa Arroyo-Villarino, Julia López de la Cruz, Javier Martínez-García, Erika Alfambra, Miguel Ángel Simón Marco, Javier Ampuero, Fernando Gomollón. Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver diseaseEuropean Journal of Internal Medicine 2024; 120: 99 doi: 10.1016/j.ejim.2023.10.019
10
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approachWorld Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
11
Sara Jarmakiewicz-Czaja, Aneta Sokal, Piotr Pardak, Rafał Filip, Alessandro Granito. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel DiseaseCanadian Journal of Gastroenterology and Hepatology 2022; 2022: 1 doi: 10.1155/2022/4344905
12
Rossella Maresca, Irene Mignini, Simone Varca, Valentin Calvez, Fabrizio Termite, Giorgio Esposto, Lucrezia Laterza, Franco Scaldaferri, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle TogetherInternational Journal of Molecular Sciences 2024; 25(6): 3278 doi: 10.3390/ijms25063278
13
Anca Trifan, Remus Stafie, Adrian Rotaru, Ermina Stratina, Sebastian Zenovia, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Cristina Muzica, Stefan Chiriac, Irina Girleanu, Ana-Maria Singeap, Catalin Sfarti, Camelia Cojocariu, Oana Petrea, Carol Stanciu. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation ParameterJournal of Clinical Medicine 2022; 11(19): 5959 doi: 10.3390/jcm11195959
14
Ying-Hsiang Wang, Chi-Hsiang Chung, Tien-Yu Huang, Chao-Feng Chang, Chi-Wei Yang, Wu-Chien Chien, Yi-Chiao Cheng. Association between nonalcoholic fatty liver disease and incidence of inflammatory bowel disease: a nationwide population‑based cohort studyIntestinal Research 2024;  doi: 10.5217/ir.2023.00078
15
Scott McHenry, Matthew Glover, Ali Ahmed, Quazim Alayo, Maria Zulfiqar, Daniel R Ludwig, Matthew A Ciorba, Nicholas O Davidson, Parakkal Deepak. NAFLD Is Associated With Quiescent Rather Than Active Crohn’s DiseaseInflammatory Bowel Diseases 2024; 30(5): 757 doi: 10.1093/ibd/izad129
16
Hirsh D. Trivedi, Emily W. Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D. Feuerstein, Theodore T. Pierce. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel DiseaseJournal of Clinical Gastroenterology 2023; 57(6): 610 doi: 10.1097/MCG.0000000000001727
17
Pilar Navarro, Lucía Gutiérrez-Ramírez, Antonio Tejera-Muñoz, Ángel Arias, Alfredo J. Lucendo. Systematic Review and Meta-Analysis: Prevalence of Non-Alcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Inflammatory Bowel DiseaseNutrients 2023; 15(21): 4507 doi: 10.3390/nu15214507
18
Min Xu, Tong Wu, Zhaoxia Li, Guijie Xin. Influence of genetically predicted autoimmune diseases on NAFLDFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1229570
19
Somtochukwu Onwuzo, Antoine Boustany, Mustafa Saleh, Riya Gupta, Chidera Onwuzo, Jessy Mascarenhas Monteiro, Favour Lawrence, Chukwuemeka Obuekwe, Zoya Morani, Imad Asaad. Increased Risk of Non-Alcoholic Steatohepatitis in Patients With Inflammatory Bowel Disease: A Population-Based StudyCureus 2023;  doi: 10.7759/cureus.35854
20
Rui Gaspar, Catarina Castelo Branco, Guilherme Macedo. Liver manifestations and complications in inflammatory bowel disease: A reviewWorld Journal of Hepatology 2021; 13(12): 1956-1967 doi: 10.4254/wjh.v13.i12.1956
21
Lanlan Chen, Zhongqi Fan, Xiaodong Sun, Wei Qiu, Yuguo Chen, Jianpeng Zhou, Guoyue Lv. Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver DiseaseFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.891410
22
Joseph-Kevin Igwe, Phani Keerthi Surapaneni, Erin Cruz, Cedric Cole, Kingsley Njoku, Jisoo Kim, Ugo Alaribe, Kelechi Weze, Bilal Mohammed. Bariatric Surgery and Inflammatory Bowel Disease: National Trends and Outcomes Associated with Procedural Sleeve Gastrectomy vs Historical Bariatric Surgery Among US Hospitalized Patients 2009–2020Obesity Surgery 2023; 33(11): 3472 doi: 10.1007/s11695-023-06833-7